pSH-EFIRES-P-AtAFB2-mCherry-weak NLS Citations (5)
Originally described in: An efficient auxin-inducible degron system with low basal degradation in human cells.Li S, Prasanna X, Salo VT, Vattulainen I, Ikonen E Nat Methods. 2019 Aug 26. pii: 10.1038/s41592-019-0512-x. doi: 10.1038/s41592-019-0512-x. PubMed Journal
Articles Citing pSH-EFIRES-P-AtAFB2-mCherry-weak NLS
Articles |
---|
Evaluation of the OsTIR1 and AtAFB2 AID Systems for Genome Architectural Protein Degradation in Mammalian Cells. Yunusova A, Smirnov A, Shnaider T, Lukyanchikova V, Afonnikova S, Battulin N. Front Mol Biosci. 2021 Nov 4;8:757394. doi: 10.3389/fmolb.2021.757394. eCollection 2021. PubMed |
A One-step strategy to target essential factors with auxin-inducible degron system in mouse embryonic stem cells. Li J, Dai C, Xie W, Zhang H, Huang X, Chronis C, Ye Y, Zhang W. Front Cell Dev Biol. 2022 Aug 8;10:964119. doi: 10.3389/fcell.2022.964119. eCollection 2022. PubMed |
Targeting the epigenetic reader ENL inhibits super-enhancer-driven oncogenic transcription and synergizes with BET inhibition to suppress tumor progression. Chen Y, Ying Y, Ma W, Ma H, Shi L, Gao X, Jia M, Li M, Song X, Kong W, Chen W, Zheng X, Muluh TA, Wang X, Wang M, Shu XS. Cancer Res. 2024 Jan 19. doi: 10.1158/0008-5472.CAN-23-1836. PubMed |
DOT1L stimulates MYC/Mondo transcription factor activity by promoting its degradation cycle on chromatin. Sepulveda GP, Gushchanskaia ES, Mora-Martin A, Esse R, Nikorich I, Ceballos A, Kwan J, Blum BC, Dholiya P, Emili A, Perissi V, Cardamone MD, Grishok A. bioRxiv [Preprint]. 2024 Feb 7:2024.02.06.579191. doi: 10.1101/2024.02.06.579191. PubMed |
Assessing cell lines with inducible depletion of cohesin and condensins components through analysis of metaphase chromosome morphology. Yunusova AM, Smirnov AV, Pristyazhnuk IE, Shnaider TA, Maltseva EK, Afonnikova SD, Gusev OA, Battulin NR. Vavilovskii Zhurnal Genet Selektsii. 2024 Apr;28(2):138-147. doi: 10.18699/vjgb-24-16. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.